• Trial Talks Podcast
  • COVID-19
  • Blog
  • Client Login

Clinical Technology

TargetCancer Foundation Successfully Engages and Empowers Rare Cancer Patients with Medrio

Overview TargetCancer Foundation implemented Medrio’s remote consent function in their TCF-001 TRACK study, which has an objective to determine if rare tumors can benefit from matched molecular therapy. The study is remotely enrolling a total of 400 patients in the United States using electronic informed consent. Medrio’s eClinical solution provides significant benefits to TargetCancer Foundation

Think Paper is the Safe Choice for Your Studies? Think Again.​

Think Paper is the Safe Choice for Your Studies? Think Again. Home It’s 2022—the world is embracing digitalization on a mass scale, yet 76% of healthcare organizations admit to printing their consent forms on paper. Why does the clinical trials industry continue to think that paper forms are sufficiently safe and equipped to handle their patients’ most sensitive